Genetics Home Reference: Renpenning syndrome

Renpenning syndrome is a disorder that affects almost exclusively males, causing developmental delay, moderate to severe intellectual disability and distinguishing physical features. Individuals with Renpenning syndrome typically have a short stature and a small head size (microcephaly). Characteristic facial features of this disorder include a long narrow face; outside corners of the eyes pointing upwards (palpebral fissures); a long bulbous nose, with a low-hanging separating the nostrils (hanging columella); a small space between the nose and mouth (prominent); and cup-shaped ears. Males Renpenning syndrome usually have small testes. Seizures and waste away (atrophy) of the muscles used for movement (skeletal muscles) may also occur in this disorder.

About 20 percent of people with Renpenning syndrome also have other features, which may include a gap or split in structures that make up the eye (coloboma), an opening in the roof of the mouth (cleft palate), cardiac anomalies or malformations of the anus.

Certain combinations of features that often occur in Renpenning syndrome are sometimes called by other names, such as Golabi-Ito-Hall syndrome or Sutherland-Haan. However, all these syndromes, which have the same genetic cause, are now generally grouped under the term Renpenning syndrome.

These resources address the diagnosis or management of Renpenning syndrome and may include providers of treatment.

You may also find information about the diagnosis or management of Renpenning syndrome in patient support and educational resources.

To locate a healthcare provider, see how do I find a genetics professional in my area? in the manual.

The following resources on Renpenning syndrome may be useful. These materials are written for the general public.

You may also be interested in these resources, which are designed for health professionals and researchers.

This manual provides basic information on genetics in clear language.

These links provide additional resources that may be useful to genetics.

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a genetic disease, syndrome or condition should consult with a qualified healthcare provider. See how do I find a genetics professional in my area? in the manual.

View the original article here

Read More

Genetics Home Reference: Renpenning syndrome

Renpenning syndrome is a disorder that affects almost exclusively males, causing developmental delay, moderate to severe intellectual disability and distinguishing physical features. Individuals with Renpenning syndrome typically have a short stature and a small head size (microcephaly). Characteristic facial features of this disorder include a long narrow face; outside corners of the eyes pointing upwards (palpebral fissures); a long bulbous nose, with a low-hanging separating the nostrils (hanging columella); a small space between the nose and mouth (prominent); and cup-shaped ears. Males Renpenning syndrome usually have small testes. Seizures and waste away (atrophy) of the muscles used for movement (skeletal muscles) may also occur in this disorder.

About 20 percent of people with Renpenning syndrome also have other features, which may include a gap or split in structures that make up the eye (coloboma), an opening in the roof of the mouth (cleft palate), cardiac anomalies or malformations of the anus.

Certain combinations of features that often occur in Renpenning syndrome are sometimes called by other names, such as Golabi-Ito-Hall syndrome or Sutherland-Haan. However, all these syndromes, which have the same genetic cause, are now generally grouped under the term Renpenning syndrome.

These resources address the diagnosis or management of Renpenning syndrome and may include providers of treatment.

You may also find information about the diagnosis or management of Renpenning syndrome in patient support and educational resources.

To locate a healthcare provider, see how do I find a genetics professional in my area? in the manual.

The following resources on Renpenning syndrome may be useful. These materials are written for the general public.

You may also be interested in these resources, which are designed for health professionals and researchers.

This manual provides basic information on genetics in clear language.

These links provide additional resources that may be useful to genetics.

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a genetic disease, syndrome or condition should consult with a qualified healthcare provider. See how do I find a genetics professional in my area? in the manual.

View the original article here

Read More

New topic on Genetics Home Reference: Senior-Løken syndrome

Senior syndrome – ken is a rare condition characterized by the combination of two specific functions: a kidney condition called nephronophthisis and ocular disease known as congenital Leber amaurosis.

Nephronophthisis causes fluid-filled cysts develop in the kidneys begin during childhood. These cysts affect kidney function, initially causing increased urine production (polyuria) and excessive thirst (polydipsia), general weakness and extreme tiredness (fatigue). Nephronophthisis leading to end-terminal chronic renal failure (ESRD) later in childhood or adolescence. ESRD is a life-threatening renal function insufficiency occurs when the kidneys are no longer able to filter efficiently liquids and waste products from the body.

Amaurosis congenita of Leber mainly affects the retina, that is the specialized tissue in the back of the eye that senses light and color. This condition causes vision problems, including an increased sensitivity to light (photophobia), involuntary eye movements (nystagmus) and extreme farsightedness (hyperopia). Some people with the syndrome of Senior-L ken develop signs of congenital Leber amaurosis within the first few years of life, while others do not develop vision problems until later in childhood.

These resources address the diagnosis or management of Senior-L ken and may include providers of treatment.

You may also find information about the diagnosis or management of Senior-L ken in patient support and educational resources.

To locate a healthcare provider, see how do I find a genetics professional in my area? in the manual.

The following resources on Senior syndrome-L ken may be useful. These materials are written for the general public.

You may also be interested in these resources, which are designed for health professionals and researchers.

This manual provides basic information on genetics in clear language.

These links provide additional resources that may be useful to genetics.

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a genetic disease, syndrome or condition should consult with a qualified healthcare provider. See how do I find a genetics professional in my area? in the manual.

View the original article here

Read More

New topic on Genetics Home Reference: Senior-Løken syndrome

Senior syndrome – ken is a rare condition characterized by the combination of two specific functions: a kidney condition called nephronophthisis and ocular disease known as congenital Leber amaurosis.

Nephronophthisis causes fluid-filled cysts develop in the kidneys begin during childhood. These cysts affect kidney function, initially causing increased urine production (polyuria) and excessive thirst (polydipsia), general weakness and extreme tiredness (fatigue). Nephronophthisis leading to end-terminal chronic renal failure (ESRD) later in childhood or adolescence. ESRD is a life-threatening renal function insufficiency occurs when the kidneys are no longer able to filter efficiently liquids and waste products from the body.

Amaurosis congenita of Leber mainly affects the retina, that is the specialized tissue in the back of the eye that senses light and color. This condition causes vision problems, including an increased sensitivity to light (photophobia), involuntary eye movements (nystagmus) and extreme farsightedness (hyperopia). Some people with the syndrome of Senior-L ken develop signs of congenital Leber amaurosis within the first few years of life, while others do not develop vision problems until later in childhood.

These resources address the diagnosis or management of Senior-L ken and may include providers of treatment.

You may also find information about the diagnosis or management of Senior-L ken in patient support and educational resources.

To locate a healthcare provider, see how do I find a genetics professional in my area? in the manual.

The following resources on Senior syndrome-L ken may be useful. These materials are written for the general public.

You may also be interested in these resources, which are designed for health professionals and researchers.

This manual provides basic information on genetics in clear language.

These links provide additional resources that may be useful to genetics.

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a genetic disease, syndrome or condition should consult with a qualified healthcare provider. See how do I find a genetics professional in my area? in the manual.

View the original article here

Read More

Genetics Home Reference: Primary Sclerosing Cholangitis

Primary sclerosing cholangitis is a condition that affects the bile ducts. These channels have bile (a fluid that helps Digest fats) from the liver where bile produced: cholecystitis, where the butter is held and intestine where it AIDS in digestion. Primary sclerosing cholangitis occurs due to inflammation of the bile ducts (cholangitis), which leads to scarring (sclerosis) and narrowing of tubes. As a result of the bile cannot be released cholecystitis and intestine and builds in the liver.

Primary sclerosing cholangitis is usually diagnosed around 40 years, and for unknown reasons, it affects men twice as often as women. Many people have no signs or symptoms of status when they are diagnosed, but routine blood tests disclose problems of the liver. When visible, the earliest signs and symptoms of Primary Sclerosing Cholangitis include extreme tiredness (fatigue), abdominal discomfort and severe itching (Pruritus). As the condition worsens, the people affected by the disease may develop yellowing of the skin and white eyes (Jaundice), and an enlarged spleen (Splenomegaly). Finally, arms bile loss of liver cells, causing chronic disease of the liver (cirrhosis) and liver failure. Without bile available to them fats go through the body. As a result may experience loss of weight and shortage of vitamins, which are absorbed and stored in fats (includes vitamins). They include vitamins, vitamin d helps absorb calcium and helps the bones harden, a lack of this vitamin can cause Thinning of bones (osteoporosis) in men with Primary sclerosing cholangitis.

Primary sclerosing cholangitis is often associated with another condition called INFLAMMATORY BOWEL DISEASE, which is characterized by inflammation of the intestines that causes open sores (ulcers) in the intestines and abdominal pain. It is clear, however, the reason for this link. Around 70% of people with Primary Sclerosing Cholangitis are inflammatory bowel disease, the most common form of the condition known as ulcerative colitis. In addition, the person Primary Sclerosing Cholangitis are more likely have autoimmune disorder such as diabetes mellitus type 1, celiac disease or thyroid disease than humans than people without the condition. Autoimmune disorders occur when the immune system malfunctions and attacks of organs and tissues of the body. People with Primary Sclerosing Cholangitis also have an increased risk of developing cancer, especially cancer bile ducts (cholangiocarcinoma).

An estimated 10,000 people 1 have Primary sclerosing cholangitis, a condition is diagnosed in approximately 1 in 100,000 people per year worldwide.

It is considered that the primary sclerosing cholangitis is the result of a combination of genetic factors and environmental protection. Researchers believe that genetic changes play a role in this condition, as often occurs in several family members and immediate family members of someone with Primary sclerosing cholangitis, have an increased risk of development of the State. It is likely that specific genetic differences increase the risk of people developing primary sclerosing cholangitis, and exposure to certain environmental factors trigger the disorder. However, the genetic changes which increases the susceptibility and environmental triggers, remain unclear.

There is evidence that variations in certain genes involved in immune function influence risk of developing primary sclerosing cholangitis. Most related genes belong to the family of genes known as the Antigen leukocyte count (HLA) complex. HLA complex helps the immune system to distinguish between proteins by the body with the proteins by foreign invaders (such as viruses and bacteria). Each HLA gene has many different variants of the normal, allowing each person the immune system to respond to a wide range of foreign proteins. Specific changes to several HLA genes seems to occur more frequently in people with Primary Sclerosing Cholangitis than people who do not have the disorder. These differences can dysregulate immune response units, leading to inflammation of the bile ducts in humans with Primary sclerosing cholangitis. However, this mechanism is not well understood. Scientists are studying the differences in other genes related to immune function units understand how they contribute to the risk of developing this condition.

The inheritance pattern of Primary Sclerosing Cholangitis is unknown, because many factors, genetic and environmental protection are probably involved. This condition tends to cluster in families, however, and having the victim family member is a factor of risk for developing the disease.

These resources Address the diagnosis or management of Primary sclerosing cholangitis, and may include treatment of suppliers.

You can also learn about the diagnosis or management of Primary Sclerosing Cholangitis educational resources and support to patients.

To locate a provider of health care, see how do I find a genetics professional in my area? in the manual.

The following resources with Primary Sclerosing Cholangitis may find useful. These materials are written for the general public.

Can also be interested in these resources, which are intended for health professionals and researchers.

For more information about names, see genetics Genetics Home Reference condition names guidelines and how genetic conditions and genes called? in the manual.

The manual contains basic information about genetics in clear language.

These links provide additional resources of modern genetics, which may be useful.

The resources on this page should not be used as a substitute for professional medical care or advice. Users seeking personal information of genetic disease, syndrome or condition, consult with a qualified professional care. See how you can find a genetics professional in my area? in the manual.

View the original article here

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Read More

Genetics Home Reference: Primary Sclerosing Cholangitis

Primary sclerosing cholangitis is a condition that affects the bile ducts. These channels have bile (a fluid that helps Digest fats) from the liver where bile produced: cholecystitis, where the butter is held and intestine where it AIDS in digestion. Primary sclerosing cholangitis occurs due to inflammation of the bile ducts (cholangitis), which leads to scarring (sclerosis) and narrowing of tubes. As a result of the bile cannot be released cholecystitis and intestine and builds in the liver.

Primary sclerosing cholangitis is usually diagnosed around 40 years, and for unknown reasons, it affects men twice as often as women. Many people have no signs or symptoms of status when they are diagnosed, but routine blood tests disclose problems of the liver. When visible, the earliest signs and symptoms of Primary Sclerosing Cholangitis include extreme tiredness (fatigue), abdominal discomfort and severe itching (Pruritus). As the condition worsens, the people affected by the disease may develop yellowing of the skin and white eyes (Jaundice), and an enlarged spleen (Splenomegaly). Finally, arms bile loss of liver cells, causing chronic disease of the liver (cirrhosis) and liver failure. Without bile available to them fats go through the body. As a result may experience loss of weight and shortage of vitamins, which are absorbed and stored in fats (includes vitamins). They include vitamins, vitamin d helps absorb calcium and helps the bones harden, a lack of this vitamin can cause Thinning of bones (osteoporosis) in men with Primary sclerosing cholangitis.

Primary sclerosing cholangitis is often associated with another condition called INFLAMMATORY BOWEL DISEASE, which is characterized by inflammation of the intestines that causes open sores (ulcers) in the intestines and abdominal pain. It is clear, however, the reason for this link. Around 70% of people with Primary Sclerosing Cholangitis are inflammatory bowel disease, the most common form of the condition known as ulcerative colitis. In addition, the person Primary Sclerosing Cholangitis are more likely have autoimmune disorder such as diabetes mellitus type 1, celiac disease or thyroid disease than humans than people without the condition. Autoimmune disorders occur when the immune system malfunctions and attacks of organs and tissues of the body. People with Primary Sclerosing Cholangitis also have an increased risk of developing cancer, especially cancer bile ducts (cholangiocarcinoma).

An estimated 10,000 people 1 have Primary sclerosing cholangitis, a condition is diagnosed in approximately 1 in 100,000 people per year worldwide.

It is considered that the primary sclerosing cholangitis is the result of a combination of genetic factors and environmental protection. Researchers believe that genetic changes play a role in this condition, as often occurs in several family members and immediate family members of someone with Primary sclerosing cholangitis, have an increased risk of development of the State. It is likely that specific genetic differences increase the risk of people developing primary sclerosing cholangitis, and exposure to certain environmental factors trigger the disorder. However, the genetic changes which increases the susceptibility and environmental triggers, remain unclear.

There is evidence that variations in certain genes involved in immune function influence risk of developing primary sclerosing cholangitis. Most related genes belong to the family of genes known as the Antigen leukocyte count (HLA) complex. HLA complex helps the immune system to distinguish between proteins by the body with the proteins by foreign invaders (such as viruses and bacteria). Each HLA gene has many different variants of the normal, allowing each person the immune system to respond to a wide range of foreign proteins. Specific changes to several HLA genes seems to occur more frequently in people with Primary Sclerosing Cholangitis than people who do not have the disorder. These differences can dysregulate immune response units, leading to inflammation of the bile ducts in humans with Primary sclerosing cholangitis. However, this mechanism is not well understood. Scientists are studying the differences in other genes related to immune function units understand how they contribute to the risk of developing this condition.

The inheritance pattern of Primary Sclerosing Cholangitis is unknown, because many factors, genetic and environmental protection are probably involved. This condition tends to cluster in families, however, and having the victim family member is a factor of risk for developing the disease.

These resources Address the diagnosis or management of Primary sclerosing cholangitis, and may include treatment of suppliers.

You can also learn about the diagnosis or management of Primary Sclerosing Cholangitis educational resources and support to patients.

To locate a provider of health care, see how do I find a genetics professional in my area? in the manual.

The following resources with Primary Sclerosing Cholangitis may find useful. These materials are written for the general public.

Can also be interested in these resources, which are intended for health professionals and researchers.

For more information about names, see genetics Genetics Home Reference condition names guidelines and how genetic conditions and genes called? in the manual.

The manual contains basic information about genetics in clear language.

These links provide additional resources of modern genetics, which may be useful.

The resources on this page should not be used as a substitute for professional medical care or advice. Users seeking personal information of genetic disease, syndrome or condition, consult with a qualified professional care. See how you can find a genetics professional in my area? in the manual.

View the original article here

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Read More

Genetics Home Reference: Meckel Syndrome

Meckel syndrome is a disorder with severe signs and symptoms that affect many parts of the body. The most commonly used functions are enlarged kidneys with multiple cysts filled with; occipital encephalocele, which is similar to the sac of perforation of the brain through a hole in the back of the skull; (a) the presence of extra fingers and toes (polydactyly). Most of the people affected by the disease also have scar tissue buildup (by) in the liver.

Other signs and symptoms of Meckel Syndrome differ among people affected by the disease. The numerous irregularities in the brain and spinal cord (central nervous system) have been reported in humans with the band Diverticulum, in this group of birth defects known as neural tube defects. These defects occur when a structure called the tube Combs, the layer of cells, which eventually develops into the brain and the spinal cord, fails completely to close in the first few weeks of development of the embryo. Meckel syndrome can also cause problems with the development of eyes and other features of the face, heart, bone, urinary tract infection and the genitalia.

Because of their health problems, most of the people from the team of Meckel die before or shortly after birth. Most commonly affects infants die respiratory problems or kidney failure.

These resources Address diagnosis or Management Team Diverticulum and may include treatment of suppliers.

You can also learn about the diagnosis or Management Team Diverticulum educational resources and support to patients.

To locate a provider of health care, see how do I find a genetics professional in my area? in the manual.

The following resources about Team Diverticulum may find useful. These materials are written for the general public.

Can also be interested in these resources, which are intended for health professionals and researchers.

The manual contains basic information about genetics in clear language.

These links provide additional resources of modern genetics, which may be useful.

The resources on this page should not be used as a substitute for professional medical care or advice. Users seeking personal information of genetic disease, syndrome or condition, consult with a qualified professional care. See how you can find a genetics professional in my area? in the manual.

View the original article here

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Read More

Genetics Home Reference: Meckel Syndrome

Meckel syndrome is a disorder with severe signs and symptoms that affect many parts of the body. The most commonly used functions are enlarged kidneys with multiple cysts filled with; occipital encephalocele, which is similar to the sac of perforation of the brain through a hole in the back of the skull; (a) the presence of extra fingers and toes (polydactyly). Most of the people affected by the disease also have scar tissue buildup (by) in the liver.

Other signs and symptoms of Meckel Syndrome differ among people affected by the disease. The numerous irregularities in the brain and spinal cord (central nervous system) have been reported in humans with the band Diverticulum, in this group of birth defects known as neural tube defects. These defects occur when a structure called the tube Combs, the layer of cells, which eventually develops into the brain and the spinal cord, fails completely to close in the first few weeks of development of the embryo. Meckel syndrome can also cause problems with the development of eyes and other features of the face, heart, bone, urinary tract infection and the genitalia.

Because of their health problems, most of the people from the team of Meckel die before or shortly after birth. Most commonly affects infants die respiratory problems or kidney failure.

These resources Address diagnosis or Management Team Diverticulum and may include treatment of suppliers.

You can also learn about the diagnosis or Management Team Diverticulum educational resources and support to patients.

To locate a provider of health care, see how do I find a genetics professional in my area? in the manual.

The following resources about Team Diverticulum may find useful. These materials are written for the general public.

Can also be interested in these resources, which are intended for health professionals and researchers.

The manual contains basic information about genetics in clear language.

These links provide additional resources of modern genetics, which may be useful.

The resources on this page should not be used as a substitute for professional medical care or advice. Users seeking personal information of genetic disease, syndrome or condition, consult with a qualified professional care. See how you can find a genetics professional in my area? in the manual.

View the original article here

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Read More

Genetics Home Reference: familial acute leukemia with mutant CEBPA

Familial acute leukemia with mutant CEBPA, is one form of cancer of blood-forming tissue (bone marrow) called acute leukemia. In normal bone marrow, early blood cells called necrosis stem cells turn into several types of blood cells: white blood cells (leukocytes), which protect the body from infection, red blood cells (erythrocytes) that have oxygen and blood platelets (points), which are involved in the clotting of blood. Acute leukemia bone marrow produces a large number of abnormal white blood cells, immature, blasts called szpikowa. Instead of developing to a normal white blood cells, szpikowa blasts develop into bronchial cells leukemia. A large number of abnormal cells in the bone marrow interferes with the production of white blood cells, functional red blood cells and blood platelets.

People with familial acute leukemia with CEBPA mutated to a shortage of white blood cells (leukopenia), leading to increased susceptibility to infections. A low number of red blood cells (anemia) also occurs in this disorder, causing fatigue and weakness. People affected by the disease are also reducing the amount of blood platelets (Thrombocytopenia), which may result in easy bruising and irregular bleeding. Other symptoms of familial acute leukemia with mutant CEBPA may include the loss of the horse and weight.

Acute leukemia in General is a disease of older people, familial acute leukemia with mutant CEBPA often starts earlier in life and has been reported to occur already at the age of 4. Between 50 and 65 per cent of the persons affected to survive their disease, compared to 25 to 40 per cent of these other forms of acute leukemia. However, people with familial acute leukemia with CEBPA mutant have higher risk of a new instance of the core is the disorder after successful treatment of the initial instance.

These resources Address the diagnosis or management of familial acute leukemia with mutant CEBPA, and may include treatment of suppliers.

You can also learn about the diagnosis or management of familial acute leukemia with mutant CEBPA educational resources and support to patients.

To locate a provider of health care, see how do I find a genetics professional in my area? in the manual.

The following resources about familial acute leukemia with CEBPA mutant may find useful. These materials are written for the general public.

Can also be interested in these resources, which are intended for health professionals and researchers.

The manual contains basic information about genetics in clear language.

These links provide additional resources of modern genetics, which may be useful.

The resources on this page should not be used as a substitute for professional medical care or advice. Users seeking personal information of genetic disease, syndrome or condition, consult with a qualified professional care. See how you can find a genetics professional in my area? in the manual.

View the original article here

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Read More

Genetics Home Reference: familial acute leukemia with mutant CEBPA

Familial acute leukemia with mutant CEBPA, is one form of cancer of blood-forming tissue (bone marrow) called acute leukemia. In normal bone marrow, early blood cells called necrosis stem cells turn into several types of blood cells: white blood cells (leukocytes), which protect the body from infection, red blood cells (erythrocytes) that have oxygen and blood platelets (points), which are involved in the clotting of blood. Acute leukemia bone marrow produces a large number of abnormal white blood cells, immature, blasts called szpikowa. Instead of developing to a normal white blood cells, szpikowa blasts develop into bronchial cells leukemia. A large number of abnormal cells in the bone marrow interferes with the production of white blood cells, functional red blood cells and blood platelets.

People with familial acute leukemia with CEBPA mutated to a shortage of white blood cells (leukopenia), leading to increased susceptibility to infections. A low number of red blood cells (anemia) also occurs in this disorder, causing fatigue and weakness. People affected by the disease are also reducing the amount of blood platelets (Thrombocytopenia), which may result in easy bruising and irregular bleeding. Other symptoms of familial acute leukemia with mutant CEBPA may include the loss of the horse and weight.

Acute leukemia in General is a disease of older people, familial acute leukemia with mutant CEBPA often starts earlier in life and has been reported to occur already at the age of 4. Between 50 and 65 per cent of the persons affected to survive their disease, compared to 25 to 40 per cent of these other forms of acute leukemia. However, people with familial acute leukemia with CEBPA mutant have higher risk of a new instance of the core is the disorder after successful treatment of the initial instance.

These resources Address the diagnosis or management of familial acute leukemia with mutant CEBPA, and may include treatment of suppliers.

You can also learn about the diagnosis or management of familial acute leukemia with mutant CEBPA educational resources and support to patients.

To locate a provider of health care, see how do I find a genetics professional in my area? in the manual.

The following resources about familial acute leukemia with CEBPA mutant may find useful. These materials are written for the general public.

Can also be interested in these resources, which are intended for health professionals and researchers.

The manual contains basic information about genetics in clear language.

These links provide additional resources of modern genetics, which may be useful.

The resources on this page should not be used as a substitute for professional medical care or advice. Users seeking personal information of genetic disease, syndrome or condition, consult with a qualified professional care. See how you can find a genetics professional in my area? in the manual.

View the original article here

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Read More

Genetics Home Reference: dystonia l-dopa unresponsive

L-dopa unresponsive dystonia is a disorder that involves involuntary contractions of muscles, tremors, and other uncontrolled movements (dystonia). Features of this condition range from mild to severe. This form of dystonia is called l-dopa responsive dystonia, since the signs and symptoms usually increase sustainable use of drugs known as l-dopa.

The signs and symptoms of l-dopa unresponsive dystonia usually appear during childhood, usually around the age of 6. The first signs of the State are usually the development-and upwards-return rates (clubfeet) and dystonia in amputation. Dystonia spreads on hand at the time; beginning in adolescence, the whole body is usually involved. People affected by the disease may have abnormal limb positioning and lack of coordination during walking or running. Some people with this condition have problems with sleep or episodes of depression more often than normally expected.

Over time, the people affected by the disease often develop group is the irregularity of movement called Parkinsonism. These abnormalities include unusually slow movement (bradykinesia), rigidity, tremors and inability to hold the body upright and balanced (postural instability).

Movement difficulties related to l-dopa unresponsive dystonia usually worsen with age, but to stabilize around the age of 30. Characteristic feature of l-dopa unresponsive dystonia is worsening the problems flow later in the day and the improvement of symptoms in the morning after sleep (diurnal fluctuations).

Rarely flow problems related to l-dopa unresponsive dystonia do not appear until adulthood. In such cases of adult onset Parkinsonism usually develops before the dystonia, and movement problems are slowly increasing, and do not Show diurnal fluctuations.

L-dopa unresponsive dystonia is estimated at 1 million people around the world. However, the disorder is likely under diagnosed because the condition may not be identified in people with mild symptoms, or may be Misdiagnosed in people who are similar to other treat disorders symptoms.

A mutation of the gene GCH1 is the most common cause of dystonia l-dopa unresponsive. Rarely a mutation of the gene TH or SPR cause this condition.

Gen GCH1 instructions for making the enzyme called GTP cyclohydrolase. The enzyme is involved in the first of the three stages of production of a molecule called tetrahydrobiopterin (BH4). Gene SPR instructions for making the enzyme sepiapterin reductase, is engaged in the last stage of the production of tetrahydrobiopterin. Tetrahydrobiopterin helps you process several protein building blocks (amino acids) and is involved in the production of chemical substances called neurotransmitters that transmit signals between neurons in the brain. In particular, tetrahydrobiopterin is engaged in the production of two neurotransmitters called dopamine and serotoniny. Among the many functions of dopamine transmits signals in the brain to produce smooth physical movements and serotoniny regulates mood, emotion, sleep and appetite.

The protein produced from the gene TH. is also involved in the production of dopamine. The gene for tryptophan hydroxylase enzyme TH instructions, which helps you convert the amino acid tyrosine dopamine.

A mutation of the gene GCH1, or SPR interfere with production of tetrahydrobiopterin, which leads to a reduction in the amount of dopamine available. In the production of the enzyme tyrosine hydroxylase function reduced, leading to a reduction in the production of dopamine by TH mutation. Reduction in the amount of dopamine to interfere with the ability of the brain to produce smooth physical movements, dystonia, tremor and other problems flow associated with dystonia l-dopa unresponsive. Disorders of sleep and mood also occur in some people with GCH1 or SPR gene mutations; such disorders may result from interference in the production of serotoniny. Problems with sleep and episodes of depression are not visible in people with l-dopa unresponsive dystonia due to TH mutation, which is sometimes referred to as the band Segawa.

Some people with l-dopa unresponsive dystonia has identified mutations in the GCH1, cz, or SPR gene. Status reason in these people is unknown.

Learn more about genes GCH1, SPR and GREN.

When l-dopa unresponsive dystonia is caused by a mutation of the gene GCH1, is inherited autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to disorder. In some cases, the affected person inherits a mutation affected parent. Other cases arising from new mutations in the gene and occur in people history of the disorder in their family.

Some people who will inherit the changed gene GCH1 never expands features of dystonia l-dopa unresponsive. (This situation is known as a reduced penetrance). It is not clear Why some people with the mutated gene is the development of the disease, not the other people of the mutated gene. For unknown reasons correspond to l-dopa dystonia due to mutation of the gene GCH1 concerns females two to four times more often than males.

When TH mutations are responsible for causing l-dopa unresponsive dystonia, is inherited autosomal recessive pattern, which means both copies of the gene in each cell mutation. Autosomal recessive condition of the parents who each carry one copy of the mutated gene, but usually do not show signs and symptoms of the condition.

When l-dopa unresponsive dystonia is caused by a mutation of the gene SPR, may have autosomal recessive or, more rarely, autosomal dominant pattern of inheritance.

These resources Address the diagnosis or management of l-dopa unresponsive dystonia and may include treatment of suppliers.

You can also learn about the diagnosis or management of l-dopa unresponsive dystonia educational resources and support to patients.

To locate a provider of health care, see how do I find a genetics professional in my area? in the manual.

The following resources with l-dopa unresponsive dystonia may find useful. These materials are written for the general public.

Can also be interested in these resources, which are intended for health professionals and researchers.

Dystonia progressive with diurnal fluctuations marked DRDhereditary

For more information about names, see genetics Genetics Home Reference condition names guidelines and how genetic conditions and genes called? in the manual.

The manual contains basic information about genetics in clear language.

These links provide additional resources of modern genetics, which may be useful.

The resources on this page should not be used as a substitute for professional medical care or advice. Users seeking personal information of genetic disease, syndrome or condition, consult with a qualified professional care. See how you can find a genetics professional in my area? in the manual.

View the original article here

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Read More

Genetics Home Reference: dystonia l-dopa unresponsive

L-dopa unresponsive dystonia is a disorder that involves involuntary contractions of muscles, tremors, and other uncontrolled movements (dystonia). Features of this condition range from mild to severe. This form of dystonia is called l-dopa responsive dystonia, since the signs and symptoms usually increase sustainable use of drugs known as l-dopa.

The signs and symptoms of l-dopa unresponsive dystonia usually appear during childhood, usually around the age of 6. The first signs of the State are usually the development-and upwards-return rates (clubfeet) and dystonia in amputation. Dystonia spreads on hand at the time; beginning in adolescence, the whole body is usually involved. People affected by the disease may have abnormal limb positioning and lack of coordination during walking or running. Some people with this condition have problems with sleep or episodes of depression more often than normally expected.

Over time, the people affected by the disease often develop group is the irregularity of movement called Parkinsonism. These abnormalities include unusually slow movement (bradykinesia), rigidity, tremors and inability to hold the body upright and balanced (postural instability).

Movement difficulties related to l-dopa unresponsive dystonia usually worsen with age, but to stabilize around the age of 30. Characteristic feature of l-dopa unresponsive dystonia is worsening the problems flow later in the day and the improvement of symptoms in the morning after sleep (diurnal fluctuations).

Rarely flow problems related to l-dopa unresponsive dystonia do not appear until adulthood. In such cases of adult onset Parkinsonism usually develops before the dystonia, and movement problems are slowly increasing, and do not Show diurnal fluctuations.

L-dopa unresponsive dystonia is estimated at 1 million people around the world. However, the disorder is likely under diagnosed because the condition may not be identified in people with mild symptoms, or may be Misdiagnosed in people who are similar to other treat disorders symptoms.

A mutation of the gene GCH1 is the most common cause of dystonia l-dopa unresponsive. Rarely a mutation of the gene TH or SPR cause this condition.

Gen GCH1 instructions for making the enzyme called GTP cyclohydrolase. The enzyme is involved in the first of the three stages of production of a molecule called tetrahydrobiopterin (BH4). Gene SPR instructions for making the enzyme sepiapterin reductase, is engaged in the last stage of the production of tetrahydrobiopterin. Tetrahydrobiopterin helps you process several protein building blocks (amino acids) and is involved in the production of chemical substances called neurotransmitters that transmit signals between neurons in the brain. In particular, tetrahydrobiopterin is engaged in the production of two neurotransmitters called dopamine and serotoniny. Among the many functions of dopamine transmits signals in the brain to produce smooth physical movements and serotoniny regulates mood, emotion, sleep and appetite.

The protein produced from the gene TH. is also involved in the production of dopamine. The gene for tryptophan hydroxylase enzyme TH instructions, which helps you convert the amino acid tyrosine dopamine.

A mutation of the gene GCH1, or SPR interfere with production of tetrahydrobiopterin, which leads to a reduction in the amount of dopamine available. In the production of the enzyme tyrosine hydroxylase function reduced, leading to a reduction in the production of dopamine by TH mutation. Reduction in the amount of dopamine to interfere with the ability of the brain to produce smooth physical movements, dystonia, tremor and other problems flow associated with dystonia l-dopa unresponsive. Disorders of sleep and mood also occur in some people with GCH1 or SPR gene mutations; such disorders may result from interference in the production of serotoniny. Problems with sleep and episodes of depression are not visible in people with l-dopa unresponsive dystonia due to TH mutation, which is sometimes referred to as the band Segawa.

Some people with l-dopa unresponsive dystonia has identified mutations in the GCH1, cz, or SPR gene. Status reason in these people is unknown.

Learn more about genes GCH1, SPR and GREN.

When l-dopa unresponsive dystonia is caused by a mutation of the gene GCH1, is inherited autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to disorder. In some cases, the affected person inherits a mutation affected parent. Other cases arising from new mutations in the gene and occur in people history of the disorder in their family.

Some people who will inherit the changed gene GCH1 never expands features of dystonia l-dopa unresponsive. (This situation is known as a reduced penetrance). It is not clear Why some people with the mutated gene is the development of the disease, not the other people of the mutated gene. For unknown reasons correspond to l-dopa dystonia due to mutation of the gene GCH1 concerns females two to four times more often than males.

When TH mutations are responsible for causing l-dopa unresponsive dystonia, is inherited autosomal recessive pattern, which means both copies of the gene in each cell mutation. Autosomal recessive condition of the parents who each carry one copy of the mutated gene, but usually do not show signs and symptoms of the condition.

When l-dopa unresponsive dystonia is caused by a mutation of the gene SPR, may have autosomal recessive or, more rarely, autosomal dominant pattern of inheritance.

These resources Address the diagnosis or management of l-dopa unresponsive dystonia and may include treatment of suppliers.

You can also learn about the diagnosis or management of l-dopa unresponsive dystonia educational resources and support to patients.

To locate a provider of health care, see how do I find a genetics professional in my area? in the manual.

The following resources with l-dopa unresponsive dystonia may find useful. These materials are written for the general public.

Can also be interested in these resources, which are intended for health professionals and researchers.

Dystonia progressive with diurnal fluctuations marked DRDhereditary

For more information about names, see genetics Genetics Home Reference condition names guidelines and how genetic conditions and genes called? in the manual.

The manual contains basic information about genetics in clear language.

These links provide additional resources of modern genetics, which may be useful.

The resources on this page should not be used as a substitute for professional medical care or advice. Users seeking personal information of genetic disease, syndrome or condition, consult with a qualified professional care. See how you can find a genetics professional in my area? in the manual.

View the original article here

This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.

Read More